News

Weill Cornell Medicine and NewYork-Presbyterian investigators have built a machine-learning tool that can predict SARS-CoV-2 infection based on age, gender, race and 27 routine laboratory test results.

T-cells taken from the blood of people who recovered from a COVID-19 infection can be successfully multiplied in the lab and maintain the ability to effectively target proteins that are key to the virus’s function.

When a patient is hospitalized with COVID-19, signs of damage to the right side of the heart may indicate a greater risk of death, according to a study from investigators at Weill Cornell Medicine and NewYork-Presbyterian.

Dr. Augustine M.K. Choi, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University, has been elected to the National Academy of Medicine.

Physicians who care for the most socially disadvantaged patients were more likely to receive lower scores in a Centers for Medicare & Medicaid Services (CMS) program that financially rewards high-value care than physicians who care for more affluent populations, according to a study by Weill Cornell Medicine researchers.

Cancer patients who contracted COVID-19 during the height of the pandemic in New York City had similar outcomes to other patients with COVID-19.

Drawing on New York’s diverse population, Weill Cornell Medicine scientists have been awarded grants from the New York Genome Center (NYGC) to study how several types of cancer differ in patients with different genetic backgrounds and point to precision treatments for groups that have been historically underrepresented in cancer research. 

It began as a spark of interest in remote healthcare, gained momentum four years ago with the introduction of a suite of digital health services, then exploded when COVID-19 strained the system, making hospital and doctor visits anything but routine. Today, telemedicine—as a panel of experts at an Oct. 1 Weill Cornell Medicine webinar agreed—is no longer a futuristic idea but an immediate and vital tool for doctors and patients alike.

An intercampus research team at Weill Cornell Medicine and Cornell’s Ithaca campus has been awarded a five-year, $3.65 million grant from the National Institutes of Health (NIH) to develop a quick, inexpensive method for accurately diagnosing urinary tract infections in kidney transplant patients by carrying out molecular profiling of cell-free DNA in urine.

Dr. Manish A. Parikh, an internationally renowned clinical interventional cardiologist and educator, has been named chief of cardiology at NewYork-Presbyterian Brooklyn Methodist Hospital.

NewYork Quality Care, the accountable care organization (ACO) of NewYork-Presbyterian, Columbia University Irving Medical Center, and Weill Cornell Medicine, saved Medicare $23,288,625 in 2019 and improved the quality of care for Medicare beneficiaries, according to performance results recently released by the Centers for Medicare & Medicaid Services (CMS).

A long-standing debate among cardiologists comparing two common heart procedures is closer to being resolved.

The amount of SARS-CoV-2 virus, or “viral load,” in cancer patients and in the general inpatient population upon hospital admission may predict their risk of dying of the infection, according to a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

With the need for wide scale COVID-19 testing to allow societies reopen safely, a group from Weill Cornell Medicine and other academic medical centers and research organizations have announced the launch of a global competition for low-cost, high-quality and scalable COVID-19 tests, called the COVID-19 XPRIZE, in a letter published Aug. 20 in Nature Biotechnology.

A study by investigators at Weill Cornell Medicine and NewYork-Presbyterian aims to answer one of COVID-19’s biggest mysteries: why do some people become severely ill, while others have no symptoms?

Dr. Anna S. Nam, an assistant professor of pathology and laboratory medicine at Weill Cornell Medicine, has received a 2020 Early Independence Award from the National Institutes of Health’s (NIH) High Risk, High Reward Research program and a 2020 Burroughs Wellcome Fund Career Award for Medical Scientists. 

One of the nation’s leading colorectal surgeons, Dr. Alessio Pigazzi, has been named chief of colorectal surgery at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, effective Sept. 28. He will also serve on Weill Cornell Medicine’s faculty.

The COVID-19 pandemic will potentially lead to greater disparities in cancer care and outcomes among Black and Hispanic New Yorker.

Ear, nose and throat (ENT) faculty discuss how Weill Cornell Medicine has safely and efficiently reopened outpatient otolaryngology following disruption to practice because of COVID-19.

For the third year in a row, Weill Cornell Medicine has been awarded the Health Professions Higher Education Excellence in Diversity Health Professions Award by INSIGHT Into Diversity magazine.